DASH vs NPCE · P/E 76, rev $13.72B vs rev $79.9M
DoorDash, Inc. Class A Common Stock (DASH) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the DASH and NPCE stock pages for the full models.
Not investment advice.